NFR κ B Antibodies

Santa Cruz Biotechnology delivers a wide array of NFR κ B monoclonal antibodies for investigating nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in various cellular processes. NFR κ B monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NF-κB is a key transcription factor involved in regulating immune response, inflammation, and cell survival. Research has shown that NF-κB dysregulation plays a significant role in numerous diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions. Understanding NF-κB function and regulation is essential for developing targeted therapies and advancing knowledge of cellular signaling pathways. NFR κ B monoclonal antibodies enable precise detection and analysis of NF-κB expression, localization, and activation states. Researchers can explore molecular mechanisms underlying NF-κB-mediated cellular responses and disease progression. Advanced imaging techniques combined with NFR κ B monoclonal antibodies reveal detailed insights into protein-protein interactions and pathway dynamics. Santa Cruz Biotechnology monoclonal antibodies support scientific discovery by providing reliable tools for investigating complex cellular signaling networks and disease mechanisms.